Skip to main content
Paul Kluetz, MD, Oncology, Washington, DC

PaulGKluetzMD

Oncology • Washington, DC

Genitourinary Oncology, Hematologic Oncology

Deputy Director, Oncology Center of Excellence, U.S. FDA Assistant Professor, Georgetown University

Join to view full profile

Dr. Kluetz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kluetz's full profile

Already have an account?

  • Office

    3800 Reservoir Rd Nw
    Div Of Hospital Medicine Gorman 3
    Washington, DC 20007
    Phone+1 202-444-3976

Summary

  • Dr. Paul Kluetz is an oncologist in Washington, DC. He received his medical degree from University of Pittsburgh School of Medicine and has been in practice 14 years. He specializes in genitourinary oncology.

    • Utilizing Patient-reported Outcomes in Cancer Clinical Trials - CANCER RESEARCH

    Assessing new anticancer therapeutics in clinical trials is a vital step in evaluating the toxicity and efficacy of treatment before its approval for widespread

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2008 - 2010
  • University of Maryland
    University of MarylandResidency, Internal Medicine, 2005 - 2007
  • University of Maryland
    University of MarylandResidency, Emergency Medicine, 2003 - 2005
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 2003
  • University of Colorado at Boulder
    University of Colorado at Boulder BS, Computer Information Systems, 1989 - 1993
  • University of Colorado at Boulder
    University of Colorado at Boulder BS, Computer Information Systems, 1989 - 1993

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2011 - 2024
  • MD State Medical License
    MD State Medical License 2007 - 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Analysis of Time to Treatment Discontinuation of Targeted Therapy, Immunotherapy, and Chemotherapy in Clinical Trials of Patients with Non-Small Cell Lung Cancer  
    G R Oxnard, G M Blumenthal, P G Kluetz, R Pazdur, Annals of Oncology

Abstracts/Posters

  • 2017-2018 Hematology Drug Approvals at the Food and Drug Administration (FDA): Communication of Patient-Reported Outcomes (PRO) Information in FDA Clinical Reviews and...
    Paul Kluetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Botanical Product Use Among Multiple Myeloma Patients in Commercial Drug Trials
    Paul Kluetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Evaluating Time to Pain Progression in Multiple Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Authored Content

  • Lancet Oncology Audio Blog- Patient Reported OutcomesMay 2018

Press Mentions

  • Broadening Clinical Trial Eligibility: A Tricky Balancing Act
    Broadening Clinical Trial Eligibility: A Tricky Balancing ActAugust 16th, 2024
  • The Lonely Quest to Create a Commission to Investigate Covid-19
    The Lonely Quest to Create a Commission to Investigate Covid-19June 22nd, 2021
  • FDA Pilot Program to Communicate Patient Reported Outcomes from Cancer Clinical Trials
    FDA Pilot Program to Communicate Patient Reported Outcomes from Cancer Clinical TrialsJune 26th, 2020
  • Join now to see all

Professional Memberships

Dr. Paul Kluetz, Dr. Paul Kluetz, MD, Dr. P Kluetz, Dr. Paul G Kluetz